Really enjoyed being part of the @OncoDaily Bladder Cancer Grand Rounds at #ESMO26 So much is changing in bladder cancer but there are still plenty of questions we don’t have answers to Special thanks to @AndreaNecchi for bringing us together and leading such a great discussion
Bladder Cancer Grand Rounds happening in Madrid! 🇪🇸 Two sessions bringing the latest evidence and worldwide clinical experience together at OncoDaily Grand Rounds during ESMO 2026. Part 1, chaired by Prof. @AndreaNecchi, featured educational lectures on: • Radical cystectomy and bladder preservation — Dr. @DrFelixGuerrero • Systemic therapy advances in localised bladder cancer — Prof. @AndreaNecchi • Treatment selection and sequencing in advanced urothelial carcinoma — Dr. Sara Coca Membribes (@scocmem) • Practical management, toxicity and monitoring — Dr. María José Juan Fita Part 2, chaired by Dr. María José Juan Fita, brought worldwide experience to the discussion through shared clinical cases. The panel explored the use of enfortumab vedotin plus pembrolizumab, perioperative strategies, treatment sequencing and bladder preservation and how access and reimbursement shape everyday decisions. Joining the discussion were Dr. Sara Coca Membribes (@scocmem) (United Kingdom), Dr. @DrFelixGuerrero (Spain), Dr. Helena Kremer (Brazil), Dr. Kelvin Yan (Hong Kong, China), Dr. @DrUddiGoswami (India), Dr. Samvel Bardakhchyan (Armenia), Dr. Lazar Popovic (@LazarPo31787807) (Serbia), Prof. Chunguang Yang (China), Dr. Javier Molina Cerrillo (@JaviMolinaC) (Spain) and Dr. Kleida Mati (Albania). The same clinical scenario can lead to very different treatment choices across countries. Sharing these experiences helps us understand the gaps and what we can do better together. Thank you to all our faculty and participants for such an open and engaging discussion! This independent educational activity is supported by a grant from @AstellasUS. #OncoDaily #ESMO2026

Oct 26, 2026 · 2:05 AM UTC

2
13
454